[New drugs for small animals in 2009].
In 2009, five active pharmaceutical ingredients were released on the German market for small animals. Those are the analgesic Buprenorphin (Buprenovet®), the cytostatic Masitinib (Masivet®), the antiepileptic Phenobarbital (Phenoleptil®) and the cyclooxygenase-2-inhibitors Mavacoxib (Trocoxil®) and Robenacoxib (Onsior®). Six additional substances were authorized for additional species. Benazepril, Cefalexin, Ivermectin und Ramipril are now available for cats, Emodepsid in combination with Praziquantel is likewise authorized for dogs and the combination Imidaclopird + Moxidectin is now also available for ferrets. Furthermore, two new preparations with an interesting new pharmaceutical form were added to the market for small animals. In addition seven active pharmaceutical ingredients with approval for use in human medicine which are of potential interest for veterinary medicine, entered the market in 2009. Those are the antiepileptic Eslicarbazepinacetat, the antihemorrhagic Romiplostim, the anticoagulant Prasugrel, the vasopressin-antagonist Tolvaptan as well as the cytostatics Azacitidin, Plerixafor and Vinflunin.
Dr. Ilka Ute Emmerich, Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät der Universität Leipzig, An den Tierkliniken 15, 04103 Leipzig, E-Mail: emmerich@vetmed.uni-leipzig.de.
I U
IU
Emmerich